- Advancing Medical Technology | Boston Scientific
- About
- Careers
- Working Here
- Explore Careers
- Clinical
- Customer Service
- Finance
- Health Economics & Market Access
- Human Resources
- Information Technology
- Leadership
- Legal & Compliance
- Manufacturing & Operations
- Marketing
- Quality
- Regulatory Affairs
- Research & Development
- Sales
- Supply Chain
- Meet Carlos Arce
- Meet Jasmin Flowers
- Meet Josh Hogan
- Meet Mara LaRock
- Meet Greg Nowlin
- Meet Alejandro Herrera Velásquez
- Meet Tom Zappia
- Students
- Recruiting Scam Alert
- News
- Newsroom Deutschland
- AF und Schlaganfall Prävention
- Aortenklappen Erkrankung
- Bildergalerie
- Multimedia
- Press Kit
- Press Releases 2017
- Press Releases 2016
- Press Releases 2014
- Boston Scientific Lotus™ Valve System demonstrates strong performance
- New data for the Lotus™ Valve System announced at PCR London Valves
- Boston Scientific at EuroPCR 2014
- Boston Scientific welcomes new guidance on the use of cardiac technologies for patients with arrhythmia or heart failure
- REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System
- Press Releases 2013
- Boston Scientific Announces First Commercial Implants Of The Lotus™ Valve System in Europe
- Boston Scientific Receives CE Mark For Lotus™ Valve System
- Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial
- Boston Scientific Reports Favorable Six-Month Results From Lotus™ Valve System Clinical Trial
- Press Releases 2012
- Press Releases 2018
- Press Releases 2019
- Press Releases 2020
- Bluthochdruck
- Chronische Schmerzen
- Bildergalerie
- Multimedia
- Press Kit
- Press Releases 2015
- Press Releases 2014
- Press Releases 2013
- Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra™ Spinal Cord Stimulator System
- Boston Scientific Launches Trial To Evaluate Neurostimulation For Treatment Of Chronic Migraine
- New Survey Finds Chronic Pain Treatments Are Failing Sufferers Across Europe
- Herzrhythmusstoerungen
- Koronare Herzerkrankung
- Neurologische Erkrankungen
- Bildergalerie
- Press Kit
- Multimedia
- Press Releases 2014
- Dystonia Europe And The European Parkinson’s Disease Association (Epda) Partner With Boston Scientific In Advancing Parkinson’s And Dystonia Care [EN]
- Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For Treating Patients With Tremor [EN]
- Boston Scientific Announces One-Year Results In The VANTAGE Clinical Study Evaluating The Vercise™ DBS System [EN]
- Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Vercise™ DBS System For Patients With Parkinson's Disease [EN]
- First Patient Enrolled In Clinical Registry Assessing Boston Scientific Vercise Deep Brain Stimulation System In Patients With Parkinsons Disease [EN]
- Press Releases 2016
- Press Releases 2020
- Periphere arterielle Verschlusskrankheit
- Schweres Asthma
- Bildergalerie
- Multimedia
- Press Kit
- Press Releases 2015
- Press Releases 2013
- The Journal of Allergy and Clinical Immunology Publishes Bronchial Thermoplasty Data Demonstrating Sustained Reduction In Severe Asthma Attacks Over Five Years
- Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients with Severe Asthma
- Urologische Beschwerden und Erkrankungen
- Newsroom Italia
- Asma grave
- Galleria di immagini
- Multimedia
- Press Kit
- Archivio Comunicati Stampa 2015
- Archivio Comunicati Stampa 2013
- The Journal of Allergy and Clinical Immunology pubblica i dati sulla termoplastica bronchiale che dimostrano una riduzione sostenuta degli attacchi gravi di asma nell'arco di cinque anni
- Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients with Severe Asthma [EN]
- Disordini neurologici
- Galleria di immagini
- Press Kit
- Multimedia
- Archivio Comunicati Stampa 2014
- Dystonia Europe And The European Parkinson’s Disease Association (Epda) Partner With Boston Scientific In Advancing Parkinson’s And Dystonia Care [EN]
- Boston Scientific Announces One-Year Results In The VANTAGE Clinical Study Evaluating The Vercise™ DBS System [EN]
- Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Vercise™ DBS System For Patients With Parkinson's Disease [EN]
- First Patient Enrolled In Clinical Registry Assessing Boston Scientific Vercise Deep Brain Stimulation System In Patients With Parkinsons Disease [EN]
- Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For Treating Patients With Tremor [EN]
- Archivio Comunicati Stampa 2016
- Disturbi del ritmo cardiaco
- Galleria di immagini
- Multimedia
- Press Kit
- Archivio Comunicati Stampa 2017
- Archivio Comunicati Stampa 2015
- Save the date
- Boston Scientific annuncia il marchio CE per la compatibilità MRI dei sistemi ICD e CRT-D
- I defibrillatori sottocutanei sono adesso consigliati dalle linee guida 2015 della ESC per la gestione dei pazienti affetti da aritmie ventricolari e per la prevenzione della morte cardiaca improvvisa
- Archivio Comunicati Stampa 2014
- Dolore cronico
- Fibrillazione atriale e prevenzione ictus
- Galleria di immagini
- Multimedia
- Press Kit
- Archivio Comunicati Stampa 2017
- Archivio Comunicati Stampa 2016
- Archivio Comunicati Stampa 2015
- Boston Scientific riceve l’approvazione della FDA (Food and Drug Administration) per il dispositivo WATCHMAN™ destinato alla chiusura dell’appendice atriale sinistra
- Boston Scientific riceve il marchio CE per il dispositivo di seconda generazione per la chiusura dell'auricola sinistra (LAA), WATCHMAN FLX™
- Archivio Comunicati Stampa 2014
- Archivio Comunicati Stampa 2012
- Ipertensione
- Galleria di immagini
- Multimedia
- Press Kit
- Archivio Comunicati Stampa 2014
- New Data Continue to Show Significant and Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System [EN]
- Nuovi dati clinici dimostrano una riduzione significativa e prolungata della pressione arteriosa con Vessix™, il sistema di denervazione renale di Boston Scientific
- Patologie della valvola aortica
- Archivio Comunicati Stampa 2017
- Archivio Comunicati Stampa 2016
- Archivio Comunicati Stampa 2014
- Il Maria Cecilia Hospital di Cotignola (Ravenna) primo Ospedale in Emilia Romagna abilitato agli impianti delle valvole aortiche transcatetere di seconda generazione LOTUS™
- Nuovi dati per la valvola Lotus™ presentati al congresso PCR London Valves
- Boston Scientific a EuroPCR2014
- La Valvola Lotus™ di Boston Scientific dimostra eccellenti performance ed un forte profilo di sicurezza a sei mesi
- Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months [EN]
- Boston Scientific Announces First Commercial Implants Of The Lotus™ Valve System in Europe [EN]
- Boston Scientific Lotus™ Valve System demonstrates strong performance [EN]
- Archivio Comunicati Stampa 2013
- Archivio Comunicati Stampa 2012
- Patologie delle arterie coronariche
- Galleria di immagini
- Multimedia
- Press Kit
- Archivio Comunicati Stampa 2014
- Boston Scientific a EuroPCR2014
- Boston Scientific riporta dati significativi sulla performance dello stent Synergy™
- Boston Scientific platinum chromium coronary stent platform demonstrates low event rates through four years [EN]
- Boston Scientific Receives CE Mark Approval for REBEL™ Platinum Chromium Coronary Stent System
- I nuovi dati dal programma clinico EVOLVE dimostrano che le prestazioni di SYNERGY™ soddisfano tutti gli obiettivi principali dello studio
- Archivio Comunicati Stampa 2013
- Archivio Comunicati Stampa 2012
- Problemi di circolazione arti inferiori
- Problemi urologici
- Asma grave
- Newsroom España
- Asma grave
- Galería de Imágenes
- Multimedia
- Material de prensa
- Notas de prensa 2015
- Notas de prensa 2014
- Notas de prensa 2013
- El Journal of Allergy and Clinical Immunology publica datos sobre la termoplastia bronquial que demuestran una reducción mantenida de las crisis de asma grave a lo largo de cinco años
- Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients with Severe Asthma
- Arteriopatía periférica
- Desórdenes neurológicos
- Galería de Imágenes
- Material de prensa
- Notas de prensa 2014
- Dystonia Europe And The European Parkinson’s Disease Association (Epda) Partner With Boston Scientific In Advancing Parkinson’s And Dystonia Care [EN]
- Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For Treating Patients With Tremor [EN]
- Boston Scientific Announces One-Year Results In The VANTAGE Clinical Study Evaluating The Vercise™ DBS System [EN]
- Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Vercise™ DBS System For Patients With Parkinson's Disease [EN]
- First Patient Enrolled In Clinical Registry Assessing Boston Scientific Vercise Deep Brain Stimulation System In Patients With Parkinsons Disease [EN]
- Notas de prensa 2020
- Multimedia
- Dolor crónico
- Enfermedad de la arteria coronaria
- Enfermedad de la válvula aórtica
- Fibrilación Auricular y Prevenir el Ictus
- Galería de Imágenes
- Multimedia
- Material de prensa
- Notas de prensa 2017
- Notas de prensa 2015
- Notas de prensa 2014
- Notas de prensa 2013
- Primer paciente incluido en el registro EWOLUTION, que recopilará resultadod clínicos del mundo real con la tecnología WATCHMAN™ de Boston Scientific para el cierre de la orejuela auricular izquierda
- FDA Advisory Panel Votes Favorably on the Boston Scientific WATCHMAN™ Left Atrial Appendage Closure Device [EN]
- Hipertensión
- Portada
- Trastornos del ritmo del corazón
- Trastornos urológicos
- Asma grave
- Newsroom United Kingdom
- AF and Stroke Prevention
- Press Releases 2017
- Press Releases 2016
- Press Releases 2015
- Image Gallery
- Multimedia
- Press Kit
- Press Releases 2014
- Press Releases 2013
- FDA Advisory Panel Votes Favorably on the Boston Scientific WATCHMAN™ Left Atrial Appendage Closure Device
- First enrolment in EWOLUTION registry to collect real world clinical outcomes for Boston Scientific WATCHMAN™ Left Atrial Appendage closure technology
- Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
- New Four-Year Data From Boston Scientific Demonstrated WATCHMAN™ Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The PROTECT AF Trial
- Presentation of Preliminary Results From Boston Scientific PREVAIL Clinical Trial Now Available
- The Boston Scientific Watchman™ Device Continues To Demonstrate Positive Clinical Outcomes For Patients With Atrial Fibrillation
- Boston Scientific Updates PREVAIL Late Breaking Clinical Trials Presentation
- Press Releases 2012
- Aortic Valve Disease
- Press Releases 2020
- Press Releases 2018
- Press Releases 2017
- Press Releases 2016
- Press Releases 2015
- New data for the Lotus™ Valve System announced at PCR London Valves
- Post-market study evaluating the LOTUS™ Valve System demonstrates extremely low PVL rates
- Boston Scientific announces CE mark and FDA clearance for the Safari2™ Pre-Shaped Guidewire
- New clinical trial data assessing the Boston Scientific Lotus™ Valve System continue to support strong performance and safety profile
- Press Releases 2014
- New data for the Lotus™ Valve System announced at PCR London Valves
- Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System
- REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System
- Boston Scientific welcomes new guidance on the use of cardiac technologies for patients with arrhythmia or heart failure
- Boston Scientific at EuroPCR 2014
- Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System
- Boston Scientific Lotus™ Valve System demonstrates strong performance and safety profile at six months
- Boston Scientific Lotus™ Valve System demonstrates strong performance
- 30-day outcomes for the 250 patients enrolled in REPRISE II Extended Cohort trial presented at PCR London Valves
- Press Releases 2013
- Boston Scientific Announces First Commercial Implants Of The Lotus™ Valve System in Europe
- Boston Scientific Receives CE Mark For Lotus™ Valve System
- Boston Scientific Reports Favorable Six-Month Results From Lotus™ Valve System Clinical Trial
- Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial
- Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
- Press Releases 2012
- Chronic Pain
- Image Gallery
- Multimedia
- Press Kit
- Press Releases 2019
- Press Releases 2015
- Press Releases 2014
- Press Releases 2013
- Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra™ Spinal Cord Stimulator System
- Boston Scientific Launches Trial To Evaluate Neurostimulation For Treatment Of Chronic Migraine
- New Survey Finds Chronic Pain Treatments Are Failing Sufferers Across Europe
- Press Releases 2012
- Coronary Artery Disease
- Image Gallery
- Multimedia
- Press Kit
- Press Releases 2016
- Press Releases 2015
- Press Releases 2014
- Boston Scientific at EuroPCR 2014
- Boston Scientific Reports Strong Performance Data For SYNERGY™ Stent System
- Boston Scientific platinum chromium coronary stent platform demonstrates low event rates through four years
- Boston Scientific Receives CE Mark Approval for REBEL™ Platinum Chromium Coronary Stent System
- Boston Scientific at EuroPCR 2014
- Boston Scientific Reports Strong Performance Data For SYNERGY™ Stent System
- Boston Scientific platinum chromium coronary stent platform demonstrates low event rates through four years
- Boston Scientific Receives CE Mark Approval for REBEL™ Platinum Chromium Coronary Stent System
- New data from EVOLVE clinical program demonstrate SYNERGY™ bioabsorbable polymer stent meets key performance endpoints
- Press Releases 2013
- Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System
- Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data
- Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
- The Boston Scientific PROMUS Element™ Platinum Chromium Stent Demonstrates Continued Low Event Rates Through Three Years
- Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval
- Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System
- Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data
- Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
- The Boston Scientific PROMUS Element™ Platinum Chromium Stent Demonstrates Continued Low Event Rates Through Three Years
- Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval
- Press Releases 2012
- First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating
- Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating
- PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy
- The Boston Scientific PROMUS Element™ Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions
- PROMUS Element™ Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study
- One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
- Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients
- Landmark Analysis of Year Two Data From PLATINUM Workhorse Trial Demonstrates
- Analysis of Two Randomized Clinical Trials Identify No Cases of Longitudinal Stent Deformation With Boston Scientific Platinum Chromium Stents
- Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe
- First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating
- Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating
- PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy
- The Boston Scientific PROMUS Element™ Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions
- PROMUS Element™ Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study
- One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
- Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients
- Landmark Analysis of Year Two Data From PLATINUM Workhorse Trial Demonstrates Superior Efficacy of PROMUS Element™ Platinum Chromium Stent Compared to PROMUS® (Xience V®) Stent
- Analysis of Two Randomized Clinical Trials Identify No Cases of Longitudinal Stent Deformation With Boston Scientific Platinum Chromium Stents
- Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe
- Heart Rhythm Disorders
- Image Gallery
- Multimedia
- Press Kit
- Press Releases 2018
- Press Releases 2017
- Press Releases 2016
- Press Releases 2015
- Save the date
- Boston Scientific announces FDA and CE Mark Approval Of The EMBLEM™ S-ICD System
- Boston scientific initiates global study to assess emblem™
- Boston Scientific EMBLEM™ S-ICD System named most innovative product at EHRA EUROPACE-CARDIOSTIM 2015
- Boston Scientific announces CE mark for MRI compatible labelling for ICD and CRT-D Systems
- Subcutaneous defibrillators now recommended by the 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
- Press Releases 2014
- Boston Scientific welcomes new guidance on the use of cardiac technologies for patients with arrhythmia or heart failure
- Boston Scientific at Cardiostim 2014
- Boston Scientific announces new developments in its Electrophysiology portfolio
- Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial
- New Data Illustrate Long-Term Safety And Effectiveness Of The Boston Scientific S-ICD™ System
- New Long-term Data Demonstrate Patients with Mild Heart Failure Sustained Lower Mortality Rates After Receiving Boston Scientific CRT Defibrillators
- Boston Scientific Announces CE Mark Approval and First Implants of Ingevity™ MRI Pacing Leads
- Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging
- Press Releases 2013
- Boston Scientific Announces CE Mark Approval And First Implants Of Its Next-Generation X4 Quadripolar CRT-D Systems
- Boston Scientific Completes Acquisition Of Bard Electrophysiology
- New Data Published In EP EuroPace Journal Highlights Differences In CRT-ICD Battery Longevity Across Manufacturers
- Boston Scientific To Acquire C.R. Bard Electrophysiology Business
- First Implant Of Boston Scientific VITALIO™ Pacemaker Takes Place In Europe
- New Boston Scientific Pacemaker Family Features Technology For Adapting Pacing To Respiration
- New Analysis Suggests Lower Electrode-Related Complication Rate for Boston Scientific S-ICD® System Versus Transvenous ICD Leads
- Data From More Than 100,000 Boston Scientific Implantable Defibrillators Show Battery Longevity Projections Of Nine To 13 Years
- Boston Scientific Receives CE Mark Approval For The Rhythmia™ Mapping System
- Boston Scientific Completes First-In-Human Clinical Trial of the IntellaTip MiFi™ XP Ablation Catheter For Patients With Type 1 Atrial Flutter
- First Patient Treated In The Boston Scientific ZERO AF Clinical Trial To Evaluate The Safety And Performance Of The Blazer® Open-Irrigated Temperature Ablation Catheter
- Press Releases 2012
- Boston Scientific Begins Clinical Trial of Patients Implanted with INGEVITY™ Pacing Leads
- Boston Scientific Defibrillators Receive CE Mark for Extended Longevity
- Boston Scientific to Acquire Rhythmia Medical, Inc
- Boston Scientific Receives FDA Approval of First-in-Class S-ICD™ System for Patients at Risk of Sudden Cardiac Arrest
- Boston Scientific Launches New Implantable Defibrillation Lead In Europe And Asia
- Boston Scientific INGENIO Family of Pacemakers Receives CE Mark Approval for use in MRI Scans
- Boston Scientific S-ICD™ System Named Most Innovative Product at Cardiostim 2012
- Boston Scientific Announces First Patient Active with LATITUDE™ NXT Remote Patient Management System
- Boston Scientific Closes Cameron Health Acquisition
- Boston Scientific Announces Launch of INGENIO™ Family of Pacemakers in Europe
- Boston Scientific to Acquire Cameron Health, Inc
- Hypertension
- Image Gallery
- Multimedia
- Press Kit
- Press Releases 2014
- Press Releases 2013
- New Data Continue to Show Significant and Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System
- New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System
- Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
- Press Releases 2012
- Neurological Disorders
- Image Gallery
- Multimedia
- Press Kit
- Press Releases 2014
- Dystonia Europe And The European Parkinson’s Disease Association (Epda) Partner With Boston Scientific In Advancing Parkinson’s And Dystonia Care
- Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For Treating Patients With Tremor
- Boston Scientific Announces One-Year Results In The VANTAGE Clinical Study Evaluating The Vercise™ DBS System
- Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Vercise™ DBS System For Patients With Parkinson's Disease
- First Patient Enrolled In Clinical Registry Assessing Boston Scientific Vercise Deep Brain Stimulation System In Patients With Parkinsons Disease
- Press Releases 2015
- Press Releases 2016
- Press Releases 2018
- Press Releases 2019
- Press Releases 2020
- Peripheral artery disease
- Image Gallery
- Multimedia
- Press Kit
- Press Releases 2019
- Press Releases 2017
- Press Releases 2016
- Boston Scientific today announced that the Eluvia™ Drug-Eluting Vascular Stent System has received CE Mark and is commencing commercialization immediately in the European Union and other countries where CE Mark is recognized
- Boston Scientific has committed to serve as an official Global Partner for the World Thrombosis Day.
- Press Releases 2015
- Severe Asthma
- Image Gallery
- Multimedia
- Press Kit
- Press Releases 2015
- Press Releases 2014
- Press Releases 2013
- The Journal of Allergy and Clinical Immunology Publishes Bronchial Thermoplasty Data Demonstrating Sustained Reduction In Severe Asthma Attacks Over Five Years
- Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients with Severe Asthma
- Press Releases 2012
- Press Releases 2016
- Press Releases 2018
- Urologic Disorders and Diseases
- Congress Newsroom July 2016
- Congress Newsroom
- Boston Scientific completes CE Mark for world's first Single-Use Duodenoscope, Exalt™ Model-D
- AF and Stroke Prevention
- Newsroom Deutschland
- Medical Specialties
- Electrophysiology
- EP Portfolio Products
- Electrophysiology Products
- Submit Questions
- Device Longevity
- Electrophysiology Portfolio
- SmartCRT
- SmartCRT™ Terapia CRT personalizzata
- SmartCRT™Terapia TRC personalizada
- SmartCRT™ Personalisierte CRT-Therapie
- Heart Failure Sensor Suite
- Heart Logic
- EFFECTIVE DEFIBRILLATION without transvenous leads
- DEFIBRILLAZIONE EFFICACE senza elettrocateteri transvenosi
- PROTECTION sans toucher le coeur et les vaisseaux
- HeartLogic Heart Failure Diagnostic – Electrophysiology – Boston Scientific
- Multi-Sensor Technology - HeartLogic Heart Failure Diagnostic - Boston Scientific
- Clinical Data - HeartLogic Heart Failure Diagnostic - Boston Scientific
- Case Studies - HeartLogic Heart Failure Diagnostic - Boston Scientific
- Clinic Workflow - HeartLogic Heart Failure Diagnostic - Boston Scientific
- Products - HeartLogic Heart Failure Diagnostic - Boston Scientific
- Resources - HeartLogic Heart Failure Diagnostic - Boston Scientific
- HeartLogic Heart Failure Diagnostic – Electrophysiology Email Sign Up – Boston Scientific
- HeartLogic Heart Failure Diagnostic – Electrophysiology Email Sign Up Thank You – Boston Scientific
- ESC2019
- SICD-Best-Practices
- Cardiac mapping and ablation therapies
- POLARx cryoablation system
- Cardiac Mapping System – RHYTHMIA HDx
- Complex Cardiac Arrhythmias Mapping – RHYTHMIA HDx
- Cardiac Arrhythmia Mapping System Clinical Data – RHYTHMIA HDx
- Cardiac Arrhythmia Mapping System – RHYTHMIA HDx
- ORION Mapping Catheter – RHYTHMIA HDx
- Cardiac Mapping System ExpertCare Service Program – RHYTHMIA HDx
- Cardiac Arrhythmia Mapping System – DIRECTSENSE Technology – Boston Scientific
- Cardiac Mapping System Software – RHYTHMIA HDx
- Electroanatomical Mapping System Hardware – RHYTHMIA HDx
- Lumipoint Software Module
- Cardiac Ablation Catheters – INTELLANAV for RHYTHMIA HDx
- Electrophysiology (EP) Recording System – LABSYSTEM PRO
- Focus – A Boston Scientific Academic Series
- RHYTHMIA for all
- S-ICD PRAETORIAN Trial
- LATITUDE Remote Patient Management Solutions
- Implanting Cardiac Devices – LATITUDE Remote Patient Management – Boston Scientific
- Remote Patient Monitoring System – LATITUDE Remote Patient Management – Boston Scientific
- Clinic Device Management – LATITUDE Remote Patient Management – Boston Scientific
- Patient Data Integration – LATITUDE Remote Patient Management – Boston Scientific
- Clinical Science
- Sign up
- Procedures & Treatments
- Request a Sales Representative
- Gastroenterology
- Procedures & Treatments
- Gastroenterology Products
- News & Events
- Events
- Resources
- Request Gastroenterology Information
- EndoCares
- Endoscopia Italia
- Hot AXIOS™ for Gallbladder Drainage
- Pancreatic & Biliary Disease Management
- Infection prevention in Endoscopy - HCPs Webcast 2
- Infection prevention in Endoscopy - Nurses Webcast
- Thank you for your registration
- Thank you for your registration
- Thank you for your confirmation
- Thank you for your confirmation
- Infection prevention in Endoscopy - Marjon de Pater webcast
- Infection Prevention in Endoscopy
- Infection prevention in Endoscopy - Vleggaar Webcast
- EXALT Model D Single-use Duodenoscope
- Registration almost complete
- Registration successful
- Already registered
- Resources COVID-19
- Habib™ EndoHPB Radio Frequency Catheter
- Cholangiocarcinoma - Habib™ EndoHPB Radio Frequency Catheter - Boston Scientific
- Ampullary Neoplasm - Habib™ EndoHPB Radio Frequency Catheter - Boston Scientific
- Pancreatic Cancer - Habib™ EndoHPB Radio Frequency Catheter - Boston Scientific
- Benign Conditions - Habib™ EndoHPB Radio Frequency Catheter - Boston Scientific
- Patient Treatment Algorithm - Habib™ EndoHPB Radio Frequency Catheter - Boston Scientific
- Case Reports & Videos - Habib™ EndoHPB Radio Frequency Catheter - Boston Scientific
- Access
- ePreceptor-program-thank-you
- A Perspective on Cold Snaring
- Stay up to date
- Interventional Cardiology
- Procedures & Treatments
- Complex PCI
- Multi-vessel Disease
- Transradial Intervention
- Crossing
- Chronic Total Occlusion
- Acute Myocardial Infarction
- Plaque Modification
- Left Main
- Saphenous Vein Graft
- Small Vessel
- Education & Training
- Join Our Complex PCI CommunityUS
- Master the Complex Training Interest
- Master the Complex Training Interest
- Healio Complex PCI Hot Topics
- Join the Complex PCI Community
- Complex PCI
- Interventional Cardiology Products
- Receive Interventional Cardiology Product Updates
- Request a Sales Representative
- Submit Questions
- Sign up
- Education & Training
- Clinical Spotlight
- SYNERGY Stent EVOLVE II Clinical Trial
- PLATINUM Diversity Trial
- Lotus REPRISE III Trial
- Submit Your Questions and Comments
- Lotus Valve Implant
- Who is the right WATCHMAN patient?
- Complex PCI
- SYNERGY EVOLVE FHU 4-Year Data
- SYNERGY Science Behind the Stent
- SYNERGY Investigator-Sponsored Research
- SYNERGY EVOLVE Short DAPT Begins Enrollment
- SYNERGY Further Evidence for Early Healing
- Lotus REPRISE III Completes Enrollment
- PLATINUM Diversity Trial - Primary Endpoint
- LOTUS Edge Technology
- WATCHMAN Post-FDA Approval Comments
- SYNERGY Stent Optimal Healing
- Complex PCI Expert Insights
- InTouch Newsletter
- Calcium Treatment
- High Bleeding Risk
- Left Main
- Multi Vessel Disease
- In-Stent Restenosis
- Bifurcation
- CTO & Complex PCI
- Lesion Preparation
- Small Vessels
- PCR e-course 2020
- Procedures & Treatments
- Interventional Radiology
- Sign up for Case Library
- Educational Events
- Procedures & Treatments
- Interventional Radiology Products
- sign-up
- Request a Sales Representative
- Submit Questions
- Pelvic Pain
- BTG Joins BSC
- BTG Product Ordering and Service Support
- Endoleak Management
- Interventional Oncology Virtual Events
- Hemodialysis Access management
- Neurological Surgery
- Orthopedic Surgery
- Pain Medicine
- pulmonology
- Vascular Surgery
- Overview | Eluvia
- Drug-Eluting-technologies
- Procedures & Treatments
- Vascular Surgery Products
- Request a Sales Representative
- Request Vascular Surgery Information
- Submit Questions
- Educational Events
- sign-up
- Thank you for your registration
- Thank you for your confirmation
- Venous Therapies
- advanced-arterial-solutions
- Receive Venous Therapies Updates
- sales-rep-follow-up1
- sales-rep-follow-up2
- Venous Thromboembolism Portal
- Urology
- Ureteral Stents
- Procedures & Treatments
- Urology Products
- Education & Training
- Urology Training Request
- Contact Us - Thank You
- ams
- WCE
- News
- BPH-Overview
- Patient-Care
- Technologies-and-Treatments
- Clinical-Evidence
- Patient-Case-Studies
- Take the Quiz 1
- Take the Quiz - TEST
- Take the Quiz 2
- Take the Quiz 3
- thank-you
- double-opt-in
- update-your-preferences
- thank-you
- Thank you
- your-data-will-not-be-kept
- thank-you
- thank-you
- Quiz 1 result page
- Quiz 2 result page
- Quiz 3 result page
- MC-UAT-Take the Quiz 1
- double-opt-in-almost-complete
- Contact Us
- Tactra™ Contact Form
- Tactra™ Malleable Penile Prosthesis
- Product Experience Form
- Contact Us - Thank You
- We’re with you for what’s next
- Contact Us - Thank You
- EAU 2020 Contact Us - Thank You
- EAU 2020 Contact Us
- Contact us on SpaceOAR
- Contact Us
- The Clinical Benefits of Tria
- Contact Us - T&T Congress
- estro-congress
- Female Pelvic Medicine OLD
- Female Pelvic Medicine
- Structural Heart
- Procedures & Treatments
- Structural Heart Disease Therapies
- Join the Community
- Submit Questions
- Request a Sales Representative
- TAVI Valve - LOTUS Edge™ Aortic Valve System
- TAVI Valve - ACURATE neo2™ Aortic Valve System
- EuroPCR 2019
- TAVI Portfolio
- TAVI Valve - ACURATE neo™ Aortic Valve System
- SENTINEL™ Cerebral Protection System
- PCR London Valves 2020
- Stay up to date
- Your subscription was successful
- Update your preferences
- Stay up to date - Thank you
- Confirm your email address
- Cirse Stay up to date
- Heart Failure
- HeartLogic Heart Failure Diagnostic–Heart FailureManagement–Boston Scientific
- Multi-Sensor Technology - HeartLogic Heart Failure Diagnostic - Boston Scientific
- Clinical Data - HeartLogic Heart Failure Diagnostic - Boston Scientific
- Case Studies - HeartLogic Heart Failure Diagnostic - Boston Scientific
- Clinic Workflow - HeartLogic Heart Failure Diagnostic - Boston Scientific
- Products - HeartLogic Heart Failure Diagnostic - Boston Scientific
- Resources - HeartLogic Heart Failure Diagnostic - Boston Scientific
- HeartLogic Newsletter
- HeartLogic Heart Failure Diagnostic–Heart FailureManagement–Boston Scientific
- Electrophysiology
- HeartLogic Newsletter 3/2020
- HeartLogic Newsltetter 2/2020
- HeartLogic Newsltetter 1/2020
- HeartLogic Newsletter 4/2020
- HeartLogic Newsletter 5/2020
- HeartLogic Newsletter 6/2020
- HeartLogic Newsletter 7/2020
- HeartLogic Newsletter 8/2020
- HeartLogic Newsletter 9/2020
- Health Conditions
- Products
- Access Device: Dilatation
- Access Device: Sheath
- Accessories
- Antiretropulsion
- Artificial Urinary Sphincter
- Atherectomy Systems
- Balloons: Dilation and Extraction
- Balloons: Drug Coated
- Band Ligator
- Baskets
- Bronchial Thermoplasty
- Capital Equipment: Diagnostic
- Capital Equipment: Mapping & Navigation
- Cardiac Ablation Systems
- Catheters: Ablation
- Blazer™ Open Irrigated
- Chilli II™
- INTELLATIP MIFI™ XP Temperature Ablation Catheter
- INTELLATIP MIFI™ OI Multi-Dimensional Ablation Catheter
- INTELLANAV MIFI™ OPEN-IRRIGATED Ablation Catheter
- INTELLANAV Ablation Catheter Family
- INTELLANAV™ OPEN-IRRIGATED Ablation Catheter
- BLAZER™ II, BLAZER II HTD and BLAZER II XP
- BLAZER PRIME™
- POLARx™ Cryoablation System
- INTELLANAV STABLEPOINT™
- Catheters: Balloon
- Catheters: Drainage
- Catheters: Guide
- Catheters: Mapping
- Catheters: Support
- Catheters: Ureteral
- Cytology Brushes
- Clips
- CRT-D
- CRT-P
- CTO Systems
- Deep Brain Stimulation Systems
- Vercise Gevia™ with Neural Navigator 2
- Vercise PC DBS System
- Vercise™ DBS
- GUIDE DBS System
- Leads and Accessories
- Vercise™ PC
- Vercise Deep Brain Stimulation System
- Vercise™ Genus DBS
- Defibrillators (S-ICD, ICD)
- MINI-ICD
- s-icd-emblem
- EMBLEM™ IT
- EMBLEM™ ES
- EMBLEM™ DE
- EMBLEM™ MRI S-ICD System
- RESONATE™ EL (Extended Longevity ICD)
- VIGILANT™ EL (Extended Longevity ICD)
- MOMENTUM™ EL (Extended Longevity ICD)
- PERCIVA™ ICD
- CHARISMA™ EL (Extended Longevity ICD)
- Direct Visualization Systems
- Embolic Protection
- Embolization
- Enteral Access & Feeding Tubes
- Through The PEG (TTP) Jejunal Feeding Tube
- Balloon Replacement Gastrostomy Tubes with ENFit connection
- Standard Percutaneous Endoscopic Gastrostomy (PEG) ENFit kits
- Standard Percutaneous Endoscopic Gastrostomy (PEG) Kit
- Balloon Replacement Gastrostomy Tubes
- EndoVive Low Profile Button Kits with ENFit Replacement Gastrostomy Tube Kit
- One-Step Button™ PEG Kit With ENFit
- Forceps
- Guidewires
- Amplatz Super Stiff™ Guidewire
- PTFE Coated Guidewires
- ChoICE™ Extra Support
- ChoICE™ Floppy
- ChoICE™ PT Extra Support
- ChoICE™ PT Floppy
- Kinetix™
- Lubriglide
- PT²™ Light Support
- PT²™ Moderate Support
- Sensor
- V-14™ ControlWire™ Guidewire
- Victory™ Guidewire
- Zebra
- Dreamwire™ High Performance Guidewire
- Hydra Jagwire™ High Performance Guidewire
- NovaGold™ High Performance Guidewire
- NaviPro™ High Performance Guidewire
- SENTAI Guidewires
- Savion Guidewire
- Jagwire Revolution
- ZIPwire
- Imaging & Physiology
- Infection Prevention
- Left Atrial Appendage Closure System
- Leads
- Laser Fibers & Accessories
- Lasers, BPH and LithoTripsy
- Needles
- Pacemakers
- PCNL
- Pelvic Floor Reconstruction
- Penile Prosthesis
- Plaque Modification
- Probes
- Remote Patient Monitoring
- Renal Denervation
- Retrieval Devices
- Bagley Helical
- Escape
- Graspit
- Leslie Parachute
- OptiFlex
- Segura Hemisphere
- Tricep
- Zero Tip
- Dakota™ Nitinol Stone Retrieval Device
- RescueNet-RetrievalNet
- Rescue-Retrieval-Devices
- TrapEase™ Polyp Traps
- LithoVue Empower™ Retrieval Deployment Device
- LithoVue™ Empower
- LithoVue Empower™ OR Staff
- LithoCatch
- Gemini
- Slings: Mid-Urethral
- Slings: Suburethral
- Snares
- Sphincterotomes
- Spinal Cord Stimulator Systems
- Stents: Coronary
- Stents: Gastrointestinal
- Stents: Pulmonary
- Stents: Ureteral
- Stents: Vascular
- Thrombectomy Systems
- Transcatheter Heart Valve
- Ureteroscopes
- Uterine Tissue Removal Systems
- RF Ablation
- Catheters: Diagnostic
- Radiofrequency Ablation for Pain Management
- Lifting Agents
- Fiducial Markers
- Cryoablation
- Single-Use Scopes
- Endobronchial coils
- Selective Internal Radiation Therapy
- Hydrogel Spacers
- Impulse™ Diagnostic Catheter
- Reimbursement
- corporate-social-responsibility
- Education
- Cookie Policy
- Privacy Policy
- Terms of Use
- Copyright Notice
- GS1/GTIN Standards
- Investigator-Sponsored Research Program
- Search Results
- Virtual Patent Marking
- Page Not Found
- EU Compliance
- Disclaimer 1
- Disclaimer 2
- Electronic Invoicing
- DO NOT PUBLISH - Customer Service
- DO NOT PUBLISH - About-OLD
- DO NOT PUBLISH - Careers OLD
- Landing
- 40-years-of-advancing-science-for-life
- Corporate Clinical: GDPR Statement
- ADVANTICS
- Explore results
- ADVANTICS Service Development
- ADVANTICS Capital Financing
- ADVANTICS Performance Optimisation
- Sign up
- ADVANTICS Therapy Solutions
- Sign up Now | Creating opportunities for growth and delivering complete healthcare pathway
- Sign up Now | Creating opportunities for growth and delivering complete healthcare pathway
- Sign up Now | Leveraging data mining to identify potential candidates for left atrial appendage closure (LAAC) therapy
- Sign up Now | Identifying potential candidates for left atrial appendage closure in recurring admissions based on patient history
- Sign up Now | Strengthening the cardiology service to support TAVI therapy growth
- Your subscription was successful.
- EMEA Response to COVID-19
- Contact us - Genus
- Boston Scientific EMEA
- Webinar Policies
- EAU 2020
- Contact us - Alpha
- HCP Recovery
- MedTech Week
- Contact Us
- Contact us
- gemendosummit
